LAS VEGAS, June 1, 2025 – LedgerDomain, the trusted platform for identity and secure messaging in decentralized healthcare, proudly announces the appointment of Christopher B. McClain as its Founding Chief Revenue Officer (CRO). With over two decades of leadership experience across biotechnology, regulatory compliance, and the healthcare supply chain, McClain brings a proven track record of scaling mission-driven ventures at the intersection of innovation and patient care.
McClain’s background spans co-founding a venture-backed biotech firm, leading cross-functional teams, closing complex partnerships, and delivering transformative solutions across sectors. Prior to joining LedgerDomain, Chris served as Senior Vice President of Sales, Marketing, and Business Development at NMDP BioTherapies (formerly Be The Match BioTherapies), where he was instrumental in transforming a fledgling division into a trusted global vendor. Under his leadership, the team grew from 8 to 125 full-time equivalent team members, supporting the clinical development and commercial launch of nearly 70 cell and gene therapies to patients across the country and the world.
“We’re thrilled to welcome Chris just as the DSCSA law entered its final phase with full manufacturer go-live,” said Ben Taylor, CEO of LedgerDomain. “Our customers are already seeing real-world impact – disrupting multi-state crime rings and powering credentialed traceability at scale. Chris’s deep empathy for healthcare stakeholders, honed through decades of delivering cures in high-stakes settings, will be a powerful complement to Alex Colgan’s continued focus on product development and stakeholder success.”
“At NMDP, our mission was to nail 7,500 perfect landings a year for patients waiting on transplants,” said McClain. “At LedgerDomain, with credentialing and the Enhanced Drug Distribution Security (EDDS) Network, we now have the opportunity to help the pharmaceutical supply chain stick a billion perfect landings annually. It’s a privilege to join this team at such a pivotal moment for the industry, and for the patients we all serve.”
Chris holds degrees from UC Berkeley and lives in the Bay Area with his wife, Dr. Carolyn McClain, and their two daughters. As Founding CRO, Chris will lead LedgerDomain’s go-to-market strategy and stakeholder engagement efforts as the company continues to expand its impact in DSCSA compliance, credentialing, and secure digital workflows across the healthcare ecosystem.
About LedgerDomain
LedgerDomain is the identity and secure messaging platform for modern decentralized healthcare. Its Drummond Certified™ XATP solution enables trading partners – including global enterprises, health centers, and independent pharmacists – to meet DSCSA requirements for authentication, enhanced verification, and secure traceability. LedgerDomain helps ensure prescription drugs remain safe, effective, and accountable across the entire pharmaceutical supply chain.
For more information, visit ledgerdomain.com or contact info@ledgerdomain.com.
